Kit for treating gastrointestinal tract
AssigneeNovavax, Inc.
InventorsRobin A. Robinson, Mark W. Thompson
Life of this patent
Estimating the term…
Abstract
Methods for isolation and purification or recombinant gene products are disclosed. In particular, methods for isolation and purification of extracellular and intracellular viral gene products, including virus-like particles, are disclosed herein.
Claims52
A process for purifying a recombinant extracellular virus-like particle comprising the steps of:
- (a) harvesting a cell suspension comprising cells containing a plurality of virus-like particles to produce a harvested supernatant;
- (b) clarifying the harvested supernatant;
- (c) concentrating the clarified supernatant;
- (e) diafilterning the concentrated supernatant;
- and
- (f) recovering the purified recombinant virus-like particle.
A process for purifying an intracellular recombinant papillomavirus virus-like particle, comprising the steps of:
- (a) harvesting a cell suspension comprising cells containing the recombinant papillomavirus L1 virus-like particle to produce harvested cells;
- (b) disrupting the harvested cells to produce cell lysates containing the recombinant papillomavirus L1 virus-like particle;
- (c) clarifying the cell lysates to produce a supernatant comprising the recombinant papillomavirus L1 virus-like particle;
- (d) concentrating the recombinant papillomavirus virus-like particle in the supernatant;
- (e) diafiltering the concentrated recombinant papillomavirus virus-like particle;
- and
- (f) recovering partially-purified intracellular recombinant papillomavirus virus-like particles.
A process for purifying a recombinant papillomavirus virus-like particle, comprising the steps of:
- (a) binding the papillomavirus virus-like particle to an ion exchange chromatographic resin;
- (b) eluting the bound virus-like particle;
- and
- (c) recovering the purified recombinant papillomavirus virus-like particle.
A process for purifying a recombinant papillomavirus virus-like particle comprising the steps of
- (a) binding the papillomavirus virus-like particle to an affinity chromatographic resin,
- (b) eluting the bound virus-like particle with a salt gradient;
- and
- (c) recovering the purified recombinant papillomavirus virus-like particle.
A process for purifying a virus-like particle, comprising the steps of:
- (a) binding the virus-like particle to a cation exchange adsorptive chromatographic resin;
- (b) eluting, with a pH gradient, the virus-like particle bound to the cation exchange chromatographic resin;
- (c) binding the virus-like particle eluted in the pH-gradient eluting step to an affinity chromatographic resin;
- (d) eluting, with a salt gradient, the virus-like particle bound to the affinity chromatographic resin;
- (e) binding the virus-like particle eluted in step (d) to an anion exchange chromatographic resin;
- and
- (f) displacing the virus-like particle bound to the anion exchange chromatographic resin of step (e) with a low molecular weight polymer.
- (g) recovering the purified virus-like particle.
A process for purifying an intracellular recombinant papillomavirus chimeric virus-like particle from cells, comprising the steps of:
- (a) harvesting a cell suspension comprising co-infected cells containing the intracellular recombinant papillomavirus chimeric virus-like particle;
- (b) resuspending the harvested cells in a buffer comprising a protease inhibitor;
- (c) disrupting the resuspended cells to produce cell lysates containing recombinant papillomavirus chimeric virus-like particle;
- (d) clarifying the cell lysates to produce a supernatant comprising the recombinant papillomavirus chimeric virus-like particle;
- (e) concentrating the recombinant papillomavirus chimeric virus-like particle in the supernatant;
- (f) diafiltering the concentrated recombinant papillomavirus chimeric virus-like particle;
- and
- (g) recovering the partially-purified recombinant papillomavirus chimeric virus-like particle.
Dependencies are inferred from the claim text.